Scholarlink

<p>Circulating cytokines are widely investigated as biomarkers of immune adaptation and adverse outcomes in pregnancy, yet findings remain inconsistent across cohorts. A major under-recognized contributor to this heterogeneity is the biological matrix used for cytokine measurement-serum versus plasma. Serum formation requires ex vivo clotting, a biologically active process involving platelet activation and platelet-leukocyte interactions that can release immune mediators into the fluid phase. Pregnancy is characterized by altered platelet physiology and thrombo-inflammatory priming, suggesting that clot-associated cytokine release may plausibly be accentuated in gestation, although direct paired serum-plasma pregnancy studies remain limited. Plasma collection suppresses coagulation but introduces variability related to anticoagulant chemistry and pre-analytical handling. We argue that serum and plasma should be considered biologically non-equivalent but complementary matrices in pregnancy immunology. A matrix-conscious framework may improve reproducibility and strengthen the translational value of cytokine biomarkers in maternal health.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Blood Clotting as an Unintended Cytokine Stimulus in Pregnancy: Why Serum and Plasma are Non-Equivalent Immune Matrices

  • 期刊论文

  • 发表日期：

    2026年4月22日

查看全文
  • Charmi Trivedi,
  • Rohit Jain,
  • Vidhi Vaidya,
  • Ishita Thakkar,
  • Jhanvi Ranpuria,
  • Aarthi Sundararajan

摘要

Circulating cytokines are widely investigated as biomarkers of immune adaptation and adverse outcomes in pregnancy, yet findings remain inconsistent across cohorts. A major under-recognized contributor to this heterogeneity is the biological matrix used for cytokine measurement-serum versus plasma. Serum formation requires ex vivo clotting, a biologically active process involving platelet activation and platelet-leukocyte interactions that can release immune mediators into the fluid phase. Pregnancy is characterized by altered platelet physiology and thrombo-inflammatory priming, suggesting that clot-associated cytokine release may plausibly be accentuated in gestation, although direct paired serum-plasma pregnancy studies remain limited. Plasma collection suppresses coagulation but introduces variability related to anticoagulant chemistry and pre-analytical handling. We argue that serum and plasma should be considered biologically non-equivalent but complementary matrices in pregnancy immunology. A matrix-conscious framework may improve reproducibility and strengthen the translational value of cytokine biomarkers in maternal health.

Graphical Abstract